Post menopausal Osteoporosis

Aug 09, 2025

FemTech, short for “Female Technology,” is a rapidly growing sector in healthcare that focuses on leveraging digital tools like mobile apps, wearables, diagnostics, and telehealth to address women’s health needs. Coined by entrepreneur Ida Tin in 2016, the term captures a movement that began with menstrual tracking...

Apr 18, 2019

Amgen reveals the price of EVENITY Amgen has set the price of its newly launched Osteoporosis drug Romosozumab (Evenity). Worth USD 21,900 per annum or USD 1,825 a month, the bone-building drug was approved by the FDA recently for the treatment of Osteoporosis in postmenopausal women and now will be available i...